This Special Issue contains case studies about the experiences of women with vulvar and vaginal atrophy during treatment with ospemifene. It covers the effects of ospemifene on bone markers, its use in breast cancer survivors, and in women with dyslipidemia, urinary incontinence or VVA-related sexual dysfunction, and its concomitant use with laser therapy.